Haleon (HLN) Other Non-Current Assets (2021 - 2025)
Haleon (HLN) posted Other Non-Current Assets of $49.2 million for Q4 2025, down 53.24% on a QoQ basis from $105.2 million in Q4 2024, and down 53.24% year-over-year from $105.2 million in Q4 2024.
Haleon (HLN) Other Non-Current Assets (2021 - 2025) Analysis & Trends
Haleon's Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $49.2 million for Q4 2025.
- Quarterly Other Non-Current Assets fell 53.24% year-over-year to $49.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $49.2 million (down 53.24% YoY) and the FY2025 annual result came in at $48.8 million, down 53.46% from the prior year.
- Other Non-Current Assets was $49.2 million for Q4 2025 at Haleon, down from $105.2 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $154.8 million in Q4 2022 and bottomed at $10.8 million in Q4 2021.
- A 5-year average of $94.8 million and a median of $101.9 million in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 1335.69% — and 2025, when it tumbled 53.24%.
- Haleon's Other Non-Current Assets stood at $10.8 million in 2021, then surged by 1335.69% to $154.8 million in 2022, then fell by 8.61% to $141.5 million in 2023, then fell by 25.62% to $105.2 million in 2024, then slumped by 53.24% to $49.2 million in 2025.
- Business Quant data shows HLN's Other Non-Current Assets at $49.2 million in Q4 2025, $105.2 million in Q4 2024, and $98.5 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 4.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49.22 Mn |
| Dec 31, 2024 | 105.25 Mn |
| Jun 30, 2024 | 98.45 Mn |
| Dec 31, 2023 | 141.49 Mn |
| Jun 30, 2023 | 141.40 Mn |
| Dec 31, 2022 | 154.83 Mn |
| Jun 30, 2022 | 56.67 Mn |
| Dec 31, 2021 | 10.78 Mn |